Headache, Migraine
59
8
9
30
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.1%
3 terminated out of 59 trials
90.9%
+4.4% vs benchmark
8%
5 trials in Phase 3/4
17%
5 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (59)
Adolescent Lifestyle Medicine Headache Study
Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine
Trial Designs for Evaluating Migraine Treatment
Mind Body Balance for Pediatric Migraine
Responding With Evidence and Access for Childhood Headaches
Stellate Ganglion Blockade for Refractory Chronic Migraine
Treatment Response to GON Pulsed Radiofrequency in Elderly Patients With Chronic Migraine
Intranasal Ketorolac Trial
App-based Breathing Program for Migraine Relief
Mind and Body Approaches to Pain Reduction in Youth With Migraine
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
Prevalence and Determinants of Migraine Among Headache Patients
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Impact Questionnaire
Migraines Accepted Laser Acupuncture Compared in Blood Test of MMP2 and CGRP
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Disability Questionnaire
Work-related Burden Changes, Quantified with HEADWORK, Among Individuals Treated with Migraine Preventive Therapies.
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies